Glycemia, insulin resistance, insulin secretion, and risk of depressive symptoms in middle age

Diabetes Care

Volumn 36, Issue 4, 2013, Pages 928-934

  Akbaraly, Tasnime N ^a,b,c   Kumari, Meena ^a   Head, Jenny ^a   Ritchie, Karen ^b,c,d   Ancelin, Marie Laure ^b,c   Tabák, Adam G ^a,e   Brunner, Eric ^a   Chaudieu, Isabelle ^b,c   Marmot, Michael G ^a   Ferrie, Jane E ^a   Shipley, Martin J ^a   Kivimäki, Mika ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b INSERM U1061   (France)

^c UNIV MONTPELLIER   (France)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

^e SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; C REACTIVE PROTEIN; GLUCOSE; HYDROCORTISONE; INSULIN; INTERLEUKIN 6;

ADULT; ARTICLE; CENTER FOR EPIDEMIOLOGICAL STUDIES DEPRESSION SCALE; COHORT ANALYSIS; DEPRESSION; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HORMONE SUBSTITUTION; HUMAN; HYDROCORTISONE RELEASE; INSULIN RELEASE; INSULIN RESISTANCE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MENOPAUSE; MIDDLE AGED; PROSPECTIVE STUDY;

ADULT; BLOOD GLUCOSE; DEPRESSION; FASTING; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS;

EID: 84875452786     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc12-0239     Document Type: Article

References (38)

1. Ali S, Stone MA, Peters JL, Davies MJ, Khunti K. The prevalence of co-morbid depression in adults with type 2 diabetes: a systematic review and meta-analysis. Diabet Med 2006;23:1165-1173
2. Mezuk B, Eaton WW, Albrecht S, Golden SH.Depression and type 2 diabetes over the lifespan: a meta-analysis. Diabetes Care 2008;31:2383-2390
3. Golden SH, Lazo M, Carnethon M, et al. Examining a bidirectional association between depressive symptoms and diabetes. JAMA 2008;299:2751-2759
4. Knol MJ, Heerdink ER, Egberts AC, et al. Depressive symptoms in subjects with diagnosed and undiagnosed type 2 diabetes. Psychosom Med 2007;69:300-305
5. Musselman DL, Betan E, Larsen H, Phillips LS. Relationship of depression to diabetes types 1 and 2: epidemiology, biology, and treatment. Biol Psychiatry 2003;54:317-329
6. Talbot F, Nouwen A. A review of the relationship between depression and diabetes in adults: is there a link? Diabetes Care 2000;23:1556-1562
7. Kivimaki M, Tabak AG, Batty GD, et al. Hyperglycemia, type 2 diabetes, and depressive symptoms: the British Whitehall II study. Diabetes Care 2009;32:1867-186
8. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998;15:539-553
9. CameronOG, Kronfol Z, Greden JF, Carroll BJ. Hypothalamic-pituitary- adrenocortical activity in patients with diabetes mellitus. Arch Gen Psychiatry 1984;41:1090-109
10. Chan O, Inouye K, Riddell MC, Vranic M, Matthews SG. Diabetes and the hypothalamopituitary-adrenal (HPA) axis. Minerva Endocrinol 2003;28:87-102
11. Gale CR, Kivimaki M, Lawlor DA, Carroll D, Phillips AC, Batty GD. Fasting glucose, diagnosis of type 2 diabetes, and depression: the Vietnam Experience Study. Biol Psychiatry 2010;67:189-192
12. Hamer M, Batty GD, Kivimaki M. Haemoglobin A1C, fasting glucose and future risk of elevated depressive symptoms over 2 years of follow-up in the English Longitudinal Study of Ageing. Psychol Med 2011;41:1889-1896
13. Aujla N, Abrams KR, Davies MJ, Taub N, Skinner TC, Khunti K. The prevalence of depression in white-European and South-Asian people with impaired glucose regulation and screen-detected type 2 diabetes mellitus. PLoS ONE 2009;4:e775
14. Hamer M, Stamatakis E, Kivimaki M, Pascal Kengne A, Batty GD. Psychological distress, glycated hemoglobin, and mortality in adults with and without diabetes. Psychosom Med 2010;72:882-886
15. RheeMK, Musselman D, Ziemer DC, et al. Unrecognized glucose intolerance is not associated with depression. Screening for Impaired Glucose Tolerance study 3 (SIGT 3). Diabet Med 2008;25:1361-136
16. Adriaanse MC, Dekker JM, Heine RJ, et al. Symptoms of depression in people with impaired glucose metabolism or type 2 diabetes mellitus: The Hoorn Study. Diabet Med 2008;25:843-849
17. Holt RI, Phillips DI, Jameson KA, Cooper C, Dennison EM, Peveler RC; Hertfordshire Cohort Study Group. The relationship between depression and diabetes mellitus: findings from the Hertfordshire Cohort Study. Diabet Med 2009;26:641-648
18. Adriaanse MC, Dekker JM, Nijpels G, Heine RJ, Snoek FJ, Pouwer F. Associations between depressive symptoms and insulin resistance: the Hoorn Study. Diabetologia 2006;49:2874-2877
19. Pan A, Ye X, Franco OH, et al. Insulin resistance and depressive symptoms in middle-aged and elderly Chinese: findings from the Nutrition and Health of Aging Population in China Study. J Affect Disord 2008;109:75-82
20. Pearson S, Schmidt M, Patton G, et al. Depression and insulin resistance: cross-sectional associations in young adults. Diabetes Care 2010;33:1128-113
21. Timonen M, Laakso M, Jokelainen J, Rajala U, Meyer-Rochow VB, Keinänen-Kiukaanniemi S. Insulin resistance and depression: cross sectional study. BMJ 2005;330:17-18
22. Timonen M, Rajala U, Jokelainen J, Keinänen-Kiukaanniemi S, Meyer-Rochow VB, Räsänen P. Depressive symptoms and insulin resistance in young adult males: results from the Northern Finland 1966 birth cohort. Mol Psychiatry 2006;11: 929-933
23. Timonen M, Salmenkaita I, Jokelainen J, et al. Insulin resistance and depressive symptoms in young adult males: findings from Finnish military conscripts. Psychosom Med 2007;69:723-728
24. Lawlor DA, Ben-Shlomo Y, Ebrahim S, et al. Insulin resistance and depressive symptoms in middle aged men: findings from the Caerphilly Prospective Cohort Study. BMJ 2005;330:705-706
25. Roos C, Lidfeldt J, Agardh CD, et al. Insulin resistance and self-rated symptoms of depression in Swedish women with risk factors for diabetes: the Women's Health in the Lund Area study.Metabolism2007; 56:825-829
26. Lawlor DA, Smith GD, Ebrahim S; British Women's Heart and Health Study. Association of insulin resistance with depression: cross sectional findings from the British Women's Heart and Health Study. BMJ 2003;327:1383-1384
27. Marmot M, Brunner E. Cohort profile: the Whitehall II study. Int J Epidemiol 2005; 34:251-256
28. Tabák AG, Jokela M, Akbaraly TN, Brunner EJ, Kivimäki M, Witte DR. Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study. Lancet 2009;373: 2215-2221
29. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care 2004;27:1487-1495
30. Collett D. Modelling Survival Data in Medical Research. 2nd ed. Boca Raton, Chapman & Hall/CRC, 2003
31. Kumari M, Chandola T, Brunner E, Kivimaki M. A nonlinear relationship of generalized and central obesity with diurnal cortisol secretion in theWhitehall II study. J Clin Endocrinol Metab 2010;95: 4415-4423
32. Goldberg DP, Hillier VF. A scaled version of the General Health Questionnaire. Psychol Med 1979;9:139-145
33. Golomb BA, Tenkanen L, Alikoski T, et al. Insulin sensitivity markers: predictors of accidents and suicides in Helsinki Heart Study screenees. J Clin Epidemiol 2002; 55:767-773
34. Callahan CM, Wolinsky FD. The effect of gender and race on the measurement properties of the CES-D in older adults. Med Care 1994;32:341-356
35. Love AS, Love RJ. Measurement suitability of the Center for Epidemiological Studies-Depression Scale among older urban black men. Int JMens Health 2006 Available from http://mensstudies.metapress.com/content/ v468242581232565/?p=e789902545 b141169e82024d4ea7caf1&pi=3. Accessed 14 November 2012
36. Pradhan AD, Manson JE, RifaiN, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 2001;286:327-334
37. Weiss LA, Pan L, Abney M, Ober C. The sex-specific genetic architecture of quantitative traits in humans. Nat Genet 2006; 38:218-222
38. Tabák AG, Herder C, Rathmann W, Brunner EJ, Kivimäki M. Prediabetes: a high-risk state for diabetes development. Lancet 2012;379:2279-2290